Bisphosphonates may retrieve endothelial function in vascular diseases similar to statins' effects

European Journal of Haematology

Volumn 81, Issue 1, 2008, Pages 77-78

  Ugur Ural, A ^a   Avcu, Ferit ^a   Ozturk, Kamile ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b AKSARAY UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; DEXAMETHASONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; NITRIC OXIDE; ZOLEDRONIC ACID;

DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; LETTER; MYELOMA CELL; PRIORITY JOURNAL; VASCULAR DISEASE;

DIPHOSPHONATES; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NITRIC OXIDE; VASCULAR DISEASES;

EID: 45449113006     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2008.01068.x     Document Type: Letter

References (5)

1. Koizumi M, Nakaseko C, Ohwada C, et al. Zoledronate has an antitumor effect and induce actin rearrangement in dexamethasone-resistant myeloma cells. Eur J Haematol 2007 79 : 382 91.
2. Ural AU, Yilmaz MI, Avcu F, et al. The bisphosphonate zoledronic acid induces cytotoxicity in human myeloma cell lines with enhancing effects of dexamethasone and thalidomide. Int J Hematol 2003 78 : 443 9.
3. Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 1998 273 : 24266 71.
4. Kalinowski L, Dobrucki LW, Brovkovych V, Malinski T. Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin. Circulation 2002 105 : 933 8.
5. Aarons CB, Cohen PA, Gower A, et al. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann Surg 2007 245 : 176 84.